John Celebi's most recent trade in Sensei Biotherapeutics Inc was a trade of 5,558 Common Stock done at an average price of $0.5 . Disclosure was reported to the exchange on Feb. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sensei Biotherapeutics Inc | Celebi John | Director, PRESIDENT AND CEO | 19 Feb 2025 | 5,558 | 105,862 | - | 0.5 | 2,646 | Common Stock | |
| Sensei Biotherapeutics Inc | John Celebi | Director, PRESIDENT AND CEO | 14 Feb 2025 | 360,000 | 360,000 | - | - | Stock Option (Right to Buy) | ||
| Sensei Biotherapeutics Inc | Celebi John | Director, PRESIDENT AND CEO | 20 Dec 2024 | 355,000 | 355,000 | - | - | Stock Option (Right to Buy) | ||
| Sensei Biotherapeutics Inc | John Celebi | Director, PRESIDENT AND CEO | 15 Feb 2024 | 315,000 | 315,000 | - | - | Stock Option (Right to Buy) | ||
| Sensei Biotherapeutics Inc | John Celebi | Director, PRESIDENT AND CEO | 15 Feb 2024 | 165,889 | 165,889 | - | - | Stock Option (Right to Buy) | ||
| Sensei Biotherapeutics Inc | Celebi John | Director, PRESIDENT AND CEO | 15 Feb 2024 | 5,891 | 105,420 | - | 0.8 | 4,654 | Common Stock | |
| Sensei Biotherapeutics Inc | John Celebi | Director, President and CEO | 15 Feb 2023 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | ||
| Sensei Biotherapeutics Inc | John Celebi | Director, President and CEO | 15 Feb 2023 | 51,893 | 110,003 | - | 0 | Common Stock | ||
| Sensei Biotherapeutics Inc | John Celebi | Director, President and CEO | 15 Feb 2023 | 21,300 | 131,303 | - | 0 | Common Stock | ||
| Sensei Biotherapeutics Inc | John Celebi | Director, President and CEO | 15 Feb 2022 | 161,600 | 161,600 | - | - | Stock Option (Right to Buy) | ||
| Sensei Biotherapeutics Inc | John Celebi | Director, President and CEO | 15 Feb 2022 | 53,900 | 54,114 | - | 0 | Common Stock |